241 related articles for article (PubMed ID: 11801458)
1. Autotransplantation for chronic myeloid leukemia: is it useful?
Olavarria E
Haematologica; 2002 Jan; 87(1):3-6. PubMed ID: 11801458
[No Abstract] [Full Text] [Related]
2. [Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia].
Boqué C; Grañena A
Sangre (Barc); 1998 Apr; 43(2):155-63. PubMed ID: 9656777
[No Abstract] [Full Text] [Related]
3. Treatment options for newly diagnosed patients with chronic myeloid leukemia.
Maness LJ; McSweeney PA
Curr Hematol Rep; 2004 Jan; 3(1):54-61. PubMed ID: 14695851
[TBL] [Abstract][Full Text] [Related]
4. [Peripheral blood hematopoietic cell transplant using immunosuppressive chemotherapy without bone marrow destruction: "minitransplant"].
Gómez-Almaguer D; Ruiz-Argüelles GJ; González-Llano O; Ruiz-Argüelles A; Cantú-Rodríguez OG
Gac Med Mex; 2002; 138(3):235-9. PubMed ID: 12096391
[TBL] [Abstract][Full Text] [Related]
5. [Chronic myeloid leukemia. New prospects for marrow autotransplantation].
Carella AM; Carlier P; Nati S; Congiu A; Pierluigi D; Raffo MR
Haematologica; 1991 Jun; 76 Suppl 3():337-51. PubMed ID: 1684348
[No Abstract] [Full Text] [Related]
6. Trial results of a new combination therapy for myeloid leukaemia.
Leach S; Richardson C; Vowles JK; Charlton L
Nurs Times; 2002 Jul 16-22; 98(29):32-4. PubMed ID: 12168413
[TBL] [Abstract][Full Text] [Related]
7. [Current therapy of chronic myeloid leukemia].
Rák K
Orv Hetil; 2003 Mar; 144(9):405-12. PubMed ID: 12688234
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.
Bornhäuser M; Kröger N; Schwerdtfeger R; Schafer-Eckart K; Sayer HG; Scheid C; Stelljes M; Kienast J; Mundhenk P; Fruehauf S; Kiehl MG; Wandt H; Theuser C; Ehninger G; Zander AR;
Eur J Haematol; 2006 Jan; 76(1):9-17. PubMed ID: 16343266
[TBL] [Abstract][Full Text] [Related]
9. Relapse of chronic myeloid leukemia (CML) in lymphoid crisis after allogeneic bone marrow transplantation for CML in chronic phase with busulfan plus cyclophosphamide regimen.
Takami A; Chuhjo T; Nakao S
Haematologica; 2002 Jun; 87(6):659-61. PubMed ID: 12031925
[No Abstract] [Full Text] [Related]
10. Mobilization of autologous hematopoietic progenitors and subsequent transplantation is a safe and feasible procedure in chronic phase chronic myelogenous leukemia patients with cytogenetic resistance to imatinib.
Prebet T; Tigaud I; Hayette S; Clapisson G; Philip I; Michallet M; Nicolini FE
Haematologica; 2005 Nov; 90 Suppl():ECR36. PubMed ID: 16266927
[No Abstract] [Full Text] [Related]
11. A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts.
Yang H; Eaves C; de Lima M; Lee MS; Champlin RE; McMannis JD; Robinson SN; Niu T; Decker WK; Xing D; Ng J; Li S; Yao X; Eaves AC; Jones R; Andersson BS; Shpall EJ
Bone Marrow Transplant; 2006 Mar; 37(6):575-82. PubMed ID: 16435011
[TBL] [Abstract][Full Text] [Related]
12. Chronic myeloid leukemia.
Singhal N; Bapsy PP; Babu KG; George J
J Assoc Physicians India; 2004 May; 52():410-6. PubMed ID: 15656033
[TBL] [Abstract][Full Text] [Related]
13. Busulphan and melphalan prior to autologous transplantation for myeloid malignancies.
Cony-Makhoul P; Marit G; Boiron JM; Puntous M; Reiffers J
Bone Marrow Transplant; 1995 Jul; 16(1):69-70. PubMed ID: 7581131
[TBL] [Abstract][Full Text] [Related]
14. Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia.
Carella AM
Expert Rev Anticancer Ther; 2007 Mar; 7(3):249-51. PubMed ID: 17338645
[No Abstract] [Full Text] [Related]
15. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
de la Rubia J; Bladé J; Lahuerta JJ; Ribera JM; Martínez R; Alegre A; García-Laraña J; Fernández P; Sureda A; de Arriba F; Carrera D; Besalduch J; García Boyero R; Palomera Bernal L; Hernández MT; García PR; Pérez-Calvo J; Alcalá A; Casado LF; San Miguel J
Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253
[TBL] [Abstract][Full Text] [Related]
16. Intensive chemotherapy and autologous hematopoietic stem cell mobilization, collection and transplantation with simultaneous Imatinib therapy in patients with blast crisis chronic myeloid leukaemia.
Heim D; Friess D; Christen S; Stüssi G; Meyer-Monard S; Tichelli A; Passweg JR; Gratwohl A
Leukemia; 2006 May; 20(5):898-900. PubMed ID: 16525490
[No Abstract] [Full Text] [Related]
17. Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia with different clinical stages.
Gopcsa L; Barta A; Banyai A; Foldi J; Kalasz L; Pajor L; Gidali J; Regeczy N; Paloczi K
Acta Haematol; 2001; 106(3):100-5. PubMed ID: 11713374
[TBL] [Abstract][Full Text] [Related]
18. Imatinib mesylate (Glivec) pre-treatment does not have a negative effect on outcome of allogenic hematopoietic stem cell transplantation in Philadelphia-positive leukemias.
Tiribelli M; Marin L; Calistri E; Geromin A; Damiani D; Fanin R
Bone Marrow Transplant; 2004 Nov; 34(9):827-8. PubMed ID: 15334052
[No Abstract] [Full Text] [Related]
19. Interferon in chronic myeloid leukaemia: past and future.
Guilhot F; Roy L; Saulnier PJ; Guilhot J
Best Pract Res Clin Haematol; 2009 Sep; 22(3):315-29. PubMed ID: 19959083
[TBL] [Abstract][Full Text] [Related]
20. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
